EastCoast Bio, founded in 1995, is a global supplier of high-quality antigens, antibodies, blocking buffers, and specialized immunoassay reagents for the IVD manufacturing industry. The company is particularly well known for its leading portfolio of drugs-of-abuse, infectious disease, and veterinary antigens and antibodies, as well as its fish-derived blocking products. It continues to expand its product line to include cardiac markers, drugs of abuse, hormones, infectious diseases, serum proteins, tumor markers, and veterinary products. In June 2020, Medix Biochemica acquired EastCoast Bio to provide customers with a broader and more comprehensive portfolio of IVD raw materials.
Vicbio Biotechnology Co., Ltd. provides the full range of EastCoast Bio products.
⇨ Inquire or Order immediately ⇦
EastCoast Bio offers a wide range of antigen and antibody products covering cardiac, oncology, hormonal, and infectious disease applications. These products are characterized by high sensitivity, specificity, and stability, meeting the needs of various diagnostic fields. For example, cardiac antigens and antibodies are used in the diagnosis of heart diseases; tumor-related products are applied in early cancer screening and therapy monitoring; and infectious disease antigens and antibodies support disease diagnosis and control.
In addition to antigens and antibodies, EastCoast Bio provides a variety of reagents for immunoassays, including marine-based blockers, drugs-of-abuse (DOA) antigens and antibodies, and plasma proteins. These reagents play a critical role in immunoassay performance by enhancing accuracy and reliability.
Furthermore, the company’s product portfolio extends to mRNA vaccine-related products, compounds, modified enzymes, and other PCR-related reagents, offering expanded possibilities for life science research and clinical diagnostics.
